ArcMesa Educators
ArcMesa Educators arcmesa educators
 
home about contact February 09, 2010
Services
Partnerships
Resource Guides
CME / CE

ACS Patients and Antiplatelet Resistance antiplatelet resistanceACS Patients and Antiplatelet Resistance: Where We Are and Where We're Going.
Faculty: Deepak L. Bhatt, MD | Cindy L. Grines, MD | Peter B. Berger, MD
CME / CE credit hour: 1.5
Myocardial ischemia secondary to acute restrictions in coronary artery blood flow leads to acute coronary syndromes (ACS). Dual antiplatelet therapy with aspirin and clopidogrel is the standard of care for patients with ACS. However, resistance to these agents is associated with adverse clinical events, and is of great concern to clinicians. This educational program will review clinical data pertinent to the current state of antiplatelet therapy for the management of patients with ACS.
CME / CE  
Copyright © 2010 ArcMesa Educators, LLC. All Rights Reserved. | Privacy Statement

All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.